Chronic Fatigue Syndrome and Cancer

References

• Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. Interna-tional Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953–959.
   Google Scholar
• Kang HK, Mahan CM, Lee KY, Murphy FM, Simmens S, Young H, Levine PH. Evidence for a deployment related Gulf War Syndrome by factor analysis. Sub-mitted.
   Google Scholar
• Simmens S, Young H, Kang H, Mahan C, Kang P. The importance of factor analysis in clinical trials of chronic fatigue syndrome. Submitted.
   Google Scholar
• Caligiuri M, Murray C, Buchwald D, et al. Phenotypic and functional defi-ciency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987; 139:3306–3313.
   PubMed Web of Science ®Google Scholar
• Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28:1403–1410.
   PubMed Web of Science ®Google Scholar
• Grufferman S, Eby NIL, Huang M, Whiteside T, Sumaya CV, Saxinger WC, Herfkens RJ, Penkower L, Muldoon SB, Herberman RB. Epidemiologic investiga-tion of an outbreak of chronic fatigue-immune dysfunction syndrome in a defined population. Am J Epidemiol 1988; 128:898.
   Web of Science ®Google Scholar
• Eby NIL, Grufferman S, Huang M, Whiteside T, Sumaya C, Saxinger WC, Herberman RB. Natural killer cell activity in the chronic fatigue-immune dysfunc-tion syndrome. In: Ades EW, Lopez C, editors. Natural Killer Cells and Host De-fense. Basel: Karger, 1989; 141–145.
   Google Scholar
• Levine PH, Whiteside TL, Friberg D, Bryant J, Colclough G, Herberman RB. Dysfunction of natural killer activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol 1998; 88:96–104.
   PubMedGoogle Scholar
• von Mikeez A, Konstantinov K, Buchwald DS, Gerace L, Tan EM. High fre-quency of autoantibodies to insoluble cellular antigens in patients with chronic fa-tigue syndrome. Arthritis Rheum 1997; 40:295–305.
   Google Scholar
• Whiteside TL, Herberman RB. Role of natural killer cells in immune surveil-lance of cancer. Curr Opin Immunol 1995; 7:704–710.
   PubMed Web of Science ®Google Scholar
• Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, Ablashi DV, Salahuddin SZ, Saxinger C, Biddle R, Kikinis R, Jolesz FA, Folks T, Balachandran N, Peter JB, Gallo RC, Komaroff AL. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992; 116:103–113.
   Google Scholar
• Poore M, Snow P, Paul C. An unexplained illness in West Otago. N Z Med J 1984; 97:351–354.
   Google Scholar
• Levine PH, Jacobson S, Pocinki AG, Cheney P, Peterson D, Connelly RR, Weil R, Ablashi DV, Salahuddin SZ, Pearson GR, Hoover R. Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med 1992; 152:1611–1616.
   Google Scholar
• Levine PH, Snow PG, Ranum BA, Paul C, Holmes MJ. Epidemic neuromyas-thenia and chronic fatigue syndrome in West Otago, New Zealand. Arch Intern Med 1997; 157:750–754.
   Google Scholar
• Levine PH, Fears TR, Cummings P, Hoover RN. Cancer and a fatiguing ill-ness in northern Nevada-a causal hypothesis. Ann Epidemol 1998; 8:245–249.
   PubMed Web of Science ®Google Scholar
• Strickland PS, Levine PH, Peterson DL, O'Brien K, Fears T. Neuromyasthe-nia and chronic fatigue syndrome (CFS) in northern Nevada/California: a ten-year follow-up of an outbreak. Submitted.
   Google Scholar
• Levine PH, editor. Recent developments in chronic fatigue syndrome. Am J Med 1998; 10S:3A: ls–124s.
   Google Scholar
• Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Davey R, Pearson G, Epstein J, Brus I, Blaese RM. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Int Med 1985; 102:7–16.
   Google Scholar
• Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses, elevated anti-early antigen antibodies. Ann Int Med 1985; 102:1–7.
   PubMed Web of Science ®Google Scholar
• White PD, Thomas JM, Amess J, Grover SA, Kangro HO, Clare AW. The ex-istence of a fatigue syndrome after glandular fever. Psychol Med 1995; 25:907–916.
   PubMed Web of Science ®Google Scholar
• Levine PH, Strickler H, Manns A, Diamondstone L. Epidemiology of viruses associated with cancer. In: McCance DJ, editor. Human Tumor Viruses. Washington, DC: ASM Press, 1998; 1–49.
   Google Scholar
• McKenzie R, Straus SE. Chronic fatigue syndrome. Adv Intern Med 1995; 40:119–153.
   PubMedGoogle Scholar
• Henderson DA, Shelokov A. Epidemic neuromyasthenia: clinical syndrome? N Engl J Med 1959; 260:757–764.
   PubMed Web of Science ®Google Scholar
• Henderson DA, Shelokov A. Epidemic neuromyasthenia: clinical syndrome? N Engl J Med 1959; 260:814–818.
   PubMed Web of Science ®Google Scholar
• Shelokov A, Habel K, Verder E. Epidemic neuromyasthenia: an outbreak of poliomyelitis like illness in student nurses. N Engl J Med 1957; 257:345–355.
   Google Scholar
• Poskanzer DC, Henderson DA, Kunkle EC, Katier SS, Clemeni WB, Bond JO. Epidemic neuromyasthenia, an outbreak in Punta Gorda, Florida. N Engl J Med 1957; 257:356–364.
   PubMed Web of Science ®Google Scholar
• Levine PH, Peterson D, McNamee FL, O'Brien K, Gridley G, Hagerty M, Brady J, Fears T, Atherton M, Hoover RN. Does chronic fatigue syndrome predis-pose to non-Hodgkin's lymphoma? Cancer Res 1992; 52:5516s–5518s.
   Google Scholar
• Jaffe ES, Raffeld M, Medeiros LJ, Stetler-Stevenson M. An overview of the classification of non-Hodgkin's lymphomas: an integration of morphological and phenotypical concepts. Cancer Res 1992; 52:5447s–5452s.
   Google Scholar
• Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones if, DuBois RE, Cunningham-Rundles C, Pahwa S, Tosato G, Zegans LS, Purtilo DT, Brown N, Schooley RT, Brus I. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108:387–439.
   Google Scholar
• Straus SE. History of Chronic Fatigue Syndrome. Rev Inf Dis 1991; 13(Suppl 1): S2–S7.
   PubMedGoogle Scholar
• Demitrack, ME, Abbey SE. Historical overview and evolution of contempo-rary definitions of chronic fatigue states. In: Demitrack MA, Abbey SE, editors. Chronic Fatigue Syndrome. Rev Inf Dis, 1992; 3–35.
   Google Scholar
• Levine PH, Hoover RH, editors. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Cancer Res 1992; 52:5425s–5574s.
   Google Scholar
• Briggs NC, Levine PH: A comparative review of systemic and neurologic symptomatology in 12 outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis. Clin Infect Dis (Suppl) 1994; 18(1):532–542.
   Google Scholar
• Holmes GP, Kaplan JE, Stewart JA, Hunt RN, Pinksy PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome. JAMA 1987; 257:2297–2302.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Mathur A, Kamat D, Shapiro RS. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res (Suppl) 1992; 52(19):5465s-5467s.
   Google Scholar
• Filipovich AH, Shapiro RS, Robison L, Mertens A, Frizzera G. Lymphoprolif-erative disorders associated with immunodeficiency. In: Magrath IT, editor. The Non-Hodgkin's Lymphomas. Edward Arnold, Ltd.: London, 1990; 135–154.
   Google Scholar